by The Biomaterials market is expected to reach USD 390.92 billion by 2027, with a CAGR of 15.2% during the forecast period 2020 – 2027.
The report provides an analysis of the global Biomaterials market for the period of 2016 to 2027, wherein the period from 2020 to 2027 comprises the forecast period and 2019 is the base year. Data for 2018 is provided as historical information.
The report covers all the major trends and technologies playing a major role in the growth of the Biomaterials market over the forecast period. It also highlights various drivers, restraints and opportunities expected to influence the market’s growth during the forecast period. The study provides a holistic perspective on the market’s growth in terms of revenue in US$ Mn, across different geographical regions namely North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
Request Coronavirus Impact Analysis on this Market@ https://www.precedenceresearch.com/sample/1059
Scope of the Report
The market overview section of the report showcases the market dynamics and trends such as the drivers, restraints and opportunities that influence the current nature and future status of this market. The report also provides value chain analysis and key market indicators. The global market estimates are the result of our in-depth secondary research, primary interviews and in-house expert panel reviews. These market estimates have been analyzed by taking into account the impact of different political, social, economic, technological and legal factors along with the current market dynamics affecting the market growth.
For relevant insights, the Biomaterials market has been segmented into 5 broader regions. Trends prevalent across prominent countries of every region have been studied from seller as well as buyer perspective. The demand for every product and application varies from region to region and the same has been correctly captured by the author of report. The reader of report would be able to make critical decisions related to cross border expansion, new product launch and so on.
The market competition has been analyzed and shares held by prominent companies have been estimated. The profiles of global leading companies are described in the report. Inclusions of company profile are the overview, offerings portfolio, financial performance, strategy adopted and relevant recent collaborations. All this put together, would help the reader of report in making important business decisions.
For a better understanding of the global Biomaterials market, analysts have segmented the market. The segmentation has been done on the basis of
Market Segmentation:
By Product
- Metallic
- Ceramics
- Natural
- Polymers
By Application
- Ophthalmology
- Intraocular Lens
- Synthetic Corneas
- Ocular Tissue Replacement
- Others
- Cardiovascular
- Stents
- Sensors
- Implantable Cardiac Defibrillators
- Guidewires
- Vascular Grafts
- Pacemakers
- Others
- Dental
- Dental Implants
- Tissue Regeneration Materials
- Bone Grafts & Substitutes
- Others
- Wound Healing
- Adhesion Barrier
- Surgical Hemostats
- Fracture Healing Device
- Internal Tissue Sealant
- Skin Substitutes
- Others
- Orthopedic
- Orthobiologics
- Joint Replacement Biomaterials
- Viscosupplementation
- Spine Biomaterials
- Bioresorbable Tissue Fixation Products
- Others
- Plastic Surgery
- Soft Tissue Fillers
- Facial Wrinkle Treatment
- Bioengineered Skins
- Craniofacial Surgery
- Acellular Dermal Matrices
- Peripheral Nerve Repair
- Others
- Tissue Engineering
- Neurology
- Shunting Systems
- Neural Stem Cell Encapsulation
- Cortical Neural Prosthetics
- Hydrogel Scaffold For CNS Repair
- Others
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Regional Segmentation:
The global version of this report with a geographical classification such as North America, Europe, Asia Pacific, Middle East and Africa and Latin America. These key regions focus on the consumption of Biomaterials market. The creators of the report have studied the region’s growth potential to assist organizations in arranging their future investments. They also study the regulatory reforms and norms that are expected to impact the global market.
Get Customization on This Report@ https://www.precedenceresearch.com/customization/1059
Competitive Dynamics
The report also includes competitive profiling of the key players associated with the Biomaterials market around the globe. The important business strategies adopted by them, their market positioning, financials, SWOT analysis and recent developments have also been identified in the research report. The competitive landscape section of the report also gives an overview about the major contributing regions/countries by these key players in order to strengthen their market position in the future.
Technology advancement and rising medical application in 3D printing across emerging economies, are forcing companies to develop Biomaterials to continue the profitability of the market.
Company Profiles: Almost all major players of the global Biomaterials market is profiled in this report. The creators of the report have provided information about their recent developments in Biomaterials market, products, revenue, production, business, and company.
Target audience of the global Biomaterials market in market study:
- Evonik Industries AG
- Medtronic plc
- Berkeley Advanced Biomaterials
- Corbion
- Carpenter Technology Corporation
- Zimmer Biomet Holdings, Inc.
- Invibio Ltd.
- Covalon Technologies Ltd.
- BASF SE
- Johnson & Johnson
- Stryker Corporation
- CoorsTek Inc.
- DentsplySirona
- Collagen Matrix, Inc.
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biomaterials Market, By Product
7.1. Biomaterials Market, by Product Type, 2020-2027
7.1.1. Metallic
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Ceramics
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Natural
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Polymers
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Biomaterials Market, By Application
8.1. Biomaterials Market, by Application, 2020-2027
8.1.1.1. Ophthalmology
8.1.1.2. Market Revenue and Forecast (2016-2027)
8.1.1.3. Cardiovascular
8.1.1.4. Market Revenue and Forecast (2016-2027)
8.1.2. Dental
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Wound Healing
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Orthopedic
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Plastic Surgery
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Tissue Engineering
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Neurology
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Biomaterials Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
Chapter 10. Company Profiles
10.1. Evonik Industries AG
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Berkeley Advanced Biomaterials
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Corbion
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Carpenter Technology Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zimmer Biomet Holdings, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Invibio Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Covalon Technologies Ltd.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. BASF SE
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Johnson & Johnson
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Stryker Corporation
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. CoorsTek Inc.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. DentsplySirona
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Get Full Access of This Research Report@ https://www.precedenceresearch.com/checkout/1059
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
